Clinical Trial Update: Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomian Gland Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of 0.05% cyclosporine ophthalmic emulsion versus tear substitutes in meibomian gland dysfunction; the study is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meibomian Gland Dysfunction

Drugs mentioned

• Cyclosporine Ophthalmic Emulsion 0.05% (cyclosporine ophthalmic emulsion 0.05%)

Snippet

Sponsor: Mahidol University | Conditions: Meibomian Gland Dysfunction | Phase 4 | Status: COMPLETED